Cite Filings / ATRA / 0001306550-23-002917
Feed Companies Filings Check
Sign in
SC 13G/A

Amended Statement of Ownership

Atara Biotherapeutics, Inc. · Filed 2023-01-24 · Acc 0001306550-23-002917

Documents 1

  • SC 13G/A Amended Statement of Ownership , us0465131078_012423.txt

Around this filing

  • 2023-02-09 SC 13G/A Amended Statement of Ownership
  • 2023-01-24 SC 13G/A Amended Statement of Ownership
  • 2023-01-18 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-08-14 SCHEDULE 13G/A · Point72 Asset Management, L.P. 7.6%
  2. 2026-07-24 SCHEDULE 13D/A · Redmile Group, LLC 9.9%
  3. 2026-05-14 SCHEDULE 13D/A · Redmile Group, LLC 9.9%
  4. 2026-05-13 SCHEDULE 13G · Adage Capital Management, L.P. 8.56%
  5. 2026-05-11 SCHEDULE 13D/A · Panacea Innovation Limited 16.1%
  6. 2026-05-08 SCHEDULE 13G · Point72 Asset Management, L.P. 6.2%
  7. 2026-05-07 SCHEDULE 13G/A · EcoR1 Capital, LLC 17.4%
  8. 2026-01-14 SCHEDULE 13D/A · Panacea Innovation Limited 19.99%
  9. 2025-11-14 SCHEDULE 13D/A · Redmile Group, LLC 9.9%
  10. 2025-11-14 SCHEDULE 13G/A · EcoR1 Capital, LLC 9.9%
  11. 2025-08-19 SCHEDULE 13D/A · Panacea Innovation Limited 20.0%
  12. 2025-05-23 SCHEDULE 13D · Redmile Group, LLC 9.9%
Loading us0465131078_012423.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…